Biomaterial Database

Metformin in the treatment of non-insulin-dependent diabetes mellitus. 1995

B Saulie, and J White, and R K Campbell

UI	MeSH Term	Description	Entries
D008687	Metformin	A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)	Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D003924	Diabetes Mellitus, Type 2	A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.	Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004347	Drug Interactions	The action of a drug that may affect the activity, metabolism, or toxicity of another drug.	Drug Interaction,Interaction, Drug,Interactions, Drug
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016903	Drug Monitoring	The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.	Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug

Related Publications

B Saulie, and J White, and R K Campbell

Treatment of non-insulin-dependent diabetes mellitus with metformin.

January 1997, The Journal of the American Board of Family Practice,

B Saulie, and J White, and R K Campbell

Metformin for non-insulin-dependent diabetes mellitus.

May 1995, The Medical letter on drugs and therapeutics,

B Saulie, and J White, and R K Campbell

The combination of insulin and metformin in treatment of non-insulin-dependent diabetes mellitus.

January 1998, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,

B Saulie, and J White, and R K Campbell

Efficacy of metformin in non-insulin-dependent diabetes mellitus.

January 1996, The New England journal of medicine,

B Saulie, and J White, and R K Campbell

Efficacy of metformin in non-insulin-dependent diabetes mellitus.

January 1996, The New England journal of medicine,

B Saulie, and J White, and R K Campbell

Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.

June 1996, The Journal of family practice,

B Saulie, and J White, and R K Campbell

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

August 1995, The New England journal of medicine,